NDA 211281 · Braintree Labs
Pizensy
Lactitol · Oral
NovelLast checked: Nov 20, 2026Latest source record: Aug 17, 2021 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations
First approved
2020
Feb 12, 2020
Approved uses
1
Original approval plus efficacy supplements
Registered trials
395
111 Phase 3, 12 recruiting
FAERS reports
0
0 serious, 0 with death reported
AI brief across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.
What it is approved for
No structured label for this application in openFDA. Older and discontinued products often have none.
Approval history
Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.
2 products under this application
- PIZENSY · LACTITOL 20G · SOLUTION, ORAL · Prescription · TE TBD
- PIZENSY · LACTITOL 10GM · FOR SOLUTION, ORAL · Discontinued
Clinical trials
Interventional ClinicalTrials.gov studies with "Lactitol" as an intervention, any sponsor and status, largest first.
- Study to Evaluate the Safety of Novartis MenACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy InfantsPivotal-lookingCompleted
NovartisNovartis (NVS)
NCT00806195 · 7,744 participants · Start Dec 2008 · Primary completion Mar 2011
Drug: MenACWY-CRM197; DTaP (Diptheria, Tetanus, Pertussis) Vaccine and 6 more · For: Meningitis; Meningococcal Infection
Sites: Birmingham, Alabama; Dothan, Alabama; Tuscon, Arizona · 153 sites in all
- Study to Evaluate the Efficacy, Safety and Immunogenicity of Influenza Vaccine in Healthy Subjects (Aged 6 to <72 Months) Versus Control VaccinesPivotal-lookingCompleted
NovartisNovartis (NVS)
NCT00644059 · 4,902 participants · Start Nov 2007 · Primary completion Apr 2010
Drug: Adjuvanted trivalent inactivated subunit influenza vaccine; Non-adjuvanted trivalent inactivated subunit influenza vaccine or non-adjuvanted trivalent inactivated split influenza vaccine and 1 more · For: Influenza, Human
Sites: East Vaanta, Finland; Espoo, Finland; Helsinki, Finland · 101 sites in all
- A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In InfantsPivotal-lookingCompleted
Novartis VaccinesNovartis (NVS)
NCT00474526 · 4,545 participants · Start Mar 2007 · Primary completion Sep 2008
Drug: Meningococcal ACWY Conjugate Vaccine; DTaP-IPV-HBV and 6 more · For: Meningitis, Meningococcal
Sites: Bessemer, Alabama; Birmingham, Alabama; Downey, California · 63 sites in all
- Evaluation of 4 Artemisinin-based Combinations for Treating Uncomplicated Malaria in African ChildrenPivotal-lookingCompleted
Institute of Tropical Medicine, BelgiumAcademic, hospital or other
NCT00393679 · 4,112 participants · Start Jul 2007 · Primary completion Dec 2009
Drug: amodiaquine-artesunate (ASAQ); dihydroartemisinin-piperaquine (DHAPQ) and 2 more · For: Fever; Malaria
Sites: Bobo-Dioulasso, Burkina Faso; Lambaréné, Gabon; Manhiça, Mozambique · 8 sites in all
- Immunogenicity, Safety and Lot to Lot Consistency of Novartis Meningococcal B Recombinant Vaccine When Administered With Routine Infant Vaccinations to Healthy InfantsPivotal-lookingCompleted
Novartis VaccinesNovartis (NVS)
NCT00657709 · 3,630 participants · Start Mar 2008 · Primary completion Jan 2010
Drug: Serogroup B meningococcal Vaccine lot 1 (rMenB Lot 1); Serogroup B meningococcal Vaccine lot 2 (rMenB Lot 2) and 4 more · For: Serogroup B Meningococcal Meningitis
Sites: Hall in Tirol, Austria; Kirchdorf, Austria; Neufeld A.d. Leitha, Austria · 66 sites in all
- A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In US Adolescents and AdultsPivotal-lookingCompleted
Novartis VaccinesNovartis (NVS)
NCT00450437 · 3,539 participants · Start Mar 2007 · Primary completion Aug 2007
Drug: MenACWY CRM; Meningococcal ACWY Conjugate vaccine · For: Meningococcal Infections; Meningococcal Meningitis
Sites: Birmingham, Alabama; Tuscaloosa, Alabama; Fremont, California · 40 sites in all
- Safe and Efficacious Artemisinin-based Combination Treatments for African Pregnant Women With MalariaPivotal-lookingCompleted
Institute of Tropical Medicine, BelgiumAcademic, hospital or other
NCT00852423 · 3,428 participants · Start Jun 2010 · Primary completion Oct 2013
Drug: Dihydroartemisinin-piperaquine; Artesunate-mefloquine and 2 more · For: Malaria in Pregnancy
Sites: Nanoro, Burkina Faso; Nazoanga, Burkina Faso; Ejisu Sekyere East, Ghana · 7 sites in all
- QVA vs. Salmeterol/Fluticasone, 52-week Exacerbation Study, FLAME (EFfect of Indacaterol Glycopyronium Vs Fluticasone Salmeterol on COPD Exacerbations)Pivotal-lookingCompleted
Novartis PharmaceuticalsNovartis (NVS)
NCT01782326 · 3,362 participants · Start Jul 2013 · Primary completion Sep 2015
Drug: QVA149; Long acting B2 agonist (LABA) and inhaled corticosteroid (ICS) · For: Chronic Obstructive Pulmonary Disease (COPD)
Sites: Ciudad de Buenos Aires, Argentina; Buenos Aires, Argentina; Caba, Argentina · 499 sites in all
Most reported adverse reactions
FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.
No FAERS reports name this application.
FAERS reports by year
By the date FDA received the report.
No reports.
Recalls
0 FDA enforcement reports for this application.
No recalls on record for this application.
Shortages
FDA's drug shortage list.
Not on FDA's shortage list.
Medicare spending
CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.
Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.
Published evidence
PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.
- Constipation in adults.
Frizelle F, Barclay M · BMJ Clin Evid 2007 · Systematic Review
- Constipation in adults.
Mueller-Lissner SA, Wald A · BMJ Clin Evid 2010 · Systematic Review
- Nonabsorbable disaccharides for hepatic encephalopathy.
Als-Nielsen B, Gluud LL, Gluud C · Cochrane Database Syst Rev 2004 · Systematic Review
- Lactitol or lactulose in the treatment of chronic constipation: result of a systematic.
Maydeo A · J Indian Med Assoc 2010 · Meta-Analysis, Systematic Review
- Management of hepatic encephalopathy: focus on antibiotic therapy.
Festi D, Vestito A, Mazzella G, et al. · Digestion 2006 · Systematic Review
- Lactitol in treatment of chronic hepatic encephalopathy. A meta-analysis.
Cammà C, Fiorello F, Tinè F, et al. · Dig Dis Sci 1993 · Clinical Trial, Comparative Study
Sponsor: Braintree Labs
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.